<DOC>
	<DOCNO>NCT02876991</DOCNO>
	<brief_summary>The purpose evaluate sodium fluoride PET patient already undergone choline PET negative bone extension ( non-metastatic status ) modifies status patient concern existence bone metastasis . Secondary purpose : - To evaluate detection bone metastasis sodium fluoride PET , detect choline PET , lead change treatment - To evaluate inter-technique concordance ( choline v sodium fluoride PET ) result ( metastatic status number lesion ) - To evaluate inter-judge concordance interpretation sodium fluoride PET - To study discordance metastatic status 2 technique .</brief_summary>
	<brief_title>Evaluation Sodium Fluoride PET Identification Bone Metastases Patients Having Undergone Choline PET Occult Recurrence Prostatic Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Sodium Fluoride</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Listerine</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Prostate adenocarcinoma regardless Gleason score Patients undergone radical treatment ( prostatectomy radiotherapy ( external brachytherapy ) +/ concoadjuvant hormonal therapy ) Level Prostate Specific Antigen ( PSA ) indicate recurrence : PSA &gt; 0.2 ng/ml case prostatectomy ( 2 consecutive test less 1 month ) elevation PSA least 2 ng/ml nadir case radiotherapy brachytherapy ( 2 consecutive test less 1 month ) Negative conventional assessment ( thoracicabdominalpelvic scanner bone scintigraphy ) 6 week inclusion Patient undergone choline PET CHRU Nancy Signed informed consent Affiliation French social security Absence contraindication sodium fluoride PET Refusal impossibility inform consent Patient incapable consent Patient deprive liberty Person legal protection Person lifeanddeath emergency Drug addiction , alcoholism , psychological problem affect patient compliance Severe comorbidities Modification hormonal therapy ( applicable ) 3 month inclusion Renal insufficiency ( creatinine clearance &lt; 60 ml/min ) detect last assessment inclusion Other progressive tumor ( recovered cancer noninclusion criterion )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>choline positron emission tomography</keyword>
	<keyword>occult recurrence</keyword>
	<keyword>prostatic adenocarcinoma</keyword>
	<keyword>sodium fluoride positron emission tomography</keyword>
</DOC>